JNK3 inhibitors (Eisai)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameJNK3 inhibitors (Eisai)
Drug Alias Namecompound 229compound 737compound 733ER-181304
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP38 α mitogen-activated protein kinase inhibitorsc-Jun N-terminal kinase 3 inhibitors
TargetsP38 α mitogen-activated protein kinasec-Jun N-terminal kinase 3
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEisai Co Ltd
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A